A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations.
Saved in:
| Title: | A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations. |
|---|---|
| Authors: | Kwag E; East West Cancer Center, Daejeon Korean Medicine Hospital, Daejeon University, Daejeon 35235, Republic of Korea.; Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Kim SD; East West Cancer Center, Daejeon Korean Medicine Hospital, Daejeon University, Daejeon 35235, Republic of Korea.; Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea., Shin SH; Kosin University College of Medicine, Busan 49267, Republic of Korea., Oak C; Kosin University College of Medicine, Busan 49267, Republic of Korea., Park SJ; School of Korean Medicine and Korean Medicine Hospital, Pusan National University, Yangsan 50612, Republic of Korea., Choi JY; School of Korean Medicine and Korean Medicine Hospital, Pusan National University, Yangsan 50612, Republic of Korea., Hoon Yoon S; School of Medicine, Pusan National University Yangsan Hospital, Pusan National University, Yangsan 50612, Republic of Korea., Kang IC; College of Life and Health Sciences and BioChip Research Center, Hoseo University, Asan‑si, Chungcheongnam‑do 336‑795, Republic of Korea., Jeong MK; Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea., Woo Lee H; Ajou University School of Medicine, Suwon 16499, Republic of Korea., Bang SH; Hwirim Korean Medicine Hospital, Busan 48942, Republic of Korea., Son JW; Konyang University Hospital, Daejeon 35365, Republic of Korea., Lee S; Dankook University, Gyeonggi-do 16890, Republic of Korea., Kim SJ; Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea., Yoo HS; East West Cancer Center, Daejeon Korean Medicine Hospital, Daejeon University, Daejeon 35235, Republic of Korea. |
| Source: | Integrative cancer therapies [Integr Cancer Ther] 2024 Jan-Dec; Vol. 23, pp. 15347354241268231. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 101128834 Publication Model: Print Cited Medium: Internet ISSN: 1552-695X (Electronic) Linking ISSN: 15347354 NLM ISO Abbreviation: Integr Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39103991 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kwag+E%22">Kwag E</searchLink>; East West Cancer Center, Daejeon Korean Medicine Hospital, Daejeon University, Daejeon 35235, Republic of Korea.; Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.<br /><searchLink fieldCode="AU" term="%22Kim+SD%22">Kim SD</searchLink>; East West Cancer Center, Daejeon Korean Medicine Hospital, Daejeon University, Daejeon 35235, Republic of Korea.; Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shin+SH%22">Shin SH</searchLink>; Kosin University College of Medicine, Busan 49267, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Oak+C%22">Oak C</searchLink>; Kosin University College of Medicine, Busan 49267, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+SJ%22">Park SJ</searchLink>; School of Korean Medicine and Korean Medicine Hospital, Pusan National University, Yangsan 50612, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+JY%22">Choi JY</searchLink>; School of Korean Medicine and Korean Medicine Hospital, Pusan National University, Yangsan 50612, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Hoon+Yoon+S%22">Hoon Yoon S</searchLink>; School of Medicine, Pusan National University Yangsan Hospital, Pusan National University, Yangsan 50612, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kang+IC%22">Kang IC</searchLink>; College of Life and Health Sciences and BioChip Research Center, Hoseo University, Asan‑si, Chungcheongnam‑do 336‑795, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jeong+MK%22">Jeong MK</searchLink>; Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Woo+Lee+H%22">Woo Lee H</searchLink>; Ajou University School of Medicine, Suwon 16499, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Bang+SH%22">Bang SH</searchLink>; Hwirim Korean Medicine Hospital, Busan 48942, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Son+JW%22">Son JW</searchLink>; Konyang University Hospital, Daejeon 35365, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; Dankook University, Gyeonggi-do 16890, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+SJ%22">Kim SJ</searchLink>; Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yoo+HS%22">Yoo HS</searchLink>; East West Cancer Center, Daejeon Korean Medicine Hospital, Daejeon University, Daejeon 35235, Republic of Korea. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101128834%22">Integrative cancer therapies</searchLink> [Integr Cancer Ther] 2024 Jan-Dec; Vol. 23, pp. 15347354241268231. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101128834 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-695X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215347354%22">15347354 </searchLink><i>NLM ISO Abbreviation: </i>Integr Cancer Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39103991 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/15347354241268231 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 15347354241268231 Titles: – TitleFull: A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kwag E – PersonEntity: Name: NameFull: Kim SD – PersonEntity: Name: NameFull: Shin SH – PersonEntity: Name: NameFull: Oak C – PersonEntity: Name: NameFull: Park SJ – PersonEntity: Name: NameFull: Choi JY – PersonEntity: Name: NameFull: Hoon Yoon S – PersonEntity: Name: NameFull: Kang IC – PersonEntity: Name: NameFull: Jeong MK – PersonEntity: Name: NameFull: Woo Lee H – PersonEntity: Name: NameFull: Bang SH – PersonEntity: Name: NameFull: Son JW – PersonEntity: Name: NameFull: Lee S – PersonEntity: Name: NameFull: Kim SJ – PersonEntity: Name: NameFull: Yoo HS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2024 Jan-Dec Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1552-695X Numbering: – Type: volume Value: 23 Titles: – TitleFull: Integrative cancer therapies Type: main |
| ResultId | 1 |
